{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:38:56Z","timestamp":1787755136935,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In recent years, aspirin has become a popular agent for venous thromboembolism (VTE) prophylaxis following total joint arthroplasty (TJA). Yet patients with a history of VTE are often given more aggressive prophylactic agents because of their increased baseline risk. The purpose of this study was to assess whether aspirin is an effective prophylactic agent in patients with a history of VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a single-institution, retrospective cohort study. The electronic clinical records of 36,333 patients undergoing TJA between 2008 and 2020 were reviewed. Data on demographic characteristics, comorbidities, intraoperative factors, and postoperative complications were collected. A propensity score-matched analysis was performed, as well as a multivariate regression analysis to account for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 36,333 patients undergoing TJA, 1,087 patients (3.0%) had a history of VTE and were not receiving chronic non-aspirin. The risk for subsequent VTE was significantly higher (p = 0.03) in patients with a history of VTE (1.4%) compared with patients without prior VTE (0.9%). However, the incidence of VTE was not significantly lower (p = 0.208) in patients with a history of VTE who received aspirin (0.4%) compared with patients who received other VTE prophylaxis (1.5%). Propensity score matching showed no difference in VTE rates between the 2 groups (2.2% compared with 0.55%; p = 0.372). In a regression analysis accounting for VTE risk, the administration of aspirin was not associated with an increased risk for subsequent VTE (adjusted odds ratio, 0.32 [95% confidence interval, 0.02 to 1.66]; p = 0.274).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that, although patients with a history of VTE have an increased baseline risk for subsequent VTE, aspirin may be a suitable VTE prophylaxis in this group of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level III.<\/jats:underline>\n                      See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.21.00601","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:24:26Z","timestamp":1655213066000},"page":"1438-1446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Aspirin May Be a Suitable Prophylaxis for Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty"],"prefix":"10.2106","volume":"104","author":[{"given":"Leanne","family":"Ludwick","sequence":"first","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shohat","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Van Nest","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-3772","authenticated-orcid":false,"given":"Joseph","family":"Paladino","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-7989","authenticated-orcid":false,"given":"Jonathan","family":"Ledesma","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"issue":"9","key":"bib1-20250430","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2106\/JBJS.RVW.N.00111","article-title":"Prophylaxis against venous thromboembolism after total hip and knee arthroplasty: a critical analysis review","volume":"3","author":"Pellegrini","year":"2015","journal-title":"JBJS Rev."},{"issue":"10","key":"bib2-20250430","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.arth.2016.03.031","article-title":"Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty","volume":"31","author":"Deirmengian","year":"2016","journal-title":"J Arthroplasty."},{"issue":"9","key":"bib3-20250430","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jhm.2224","article-title":"Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis","volume":"9","author":"Drescher","year":"2014","journal-title":"J Hosp Med."},{"issue":"3","key":"bib4-20250430","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.arth.2019.09.043","article-title":"Low-dose aspirin is adequate for venous thromboembolism prevention following total joint arthroplasty: a systematic review","volume":"35","author":"Azboy","year":"2020","journal-title":"J Arthroplasty."},{"issue":"2 Suppl","key":"bib5-20250430","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest."},{"issue":"8","key":"bib6-20250430","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2106\/JBJS.9408.ebo746","article-title":"American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"94","author":"Jacobs","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib7-20250430","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12891-015-0470-0","article-title":"Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years","volume":"16","author":"Zhang","year":"2015","journal-title":"BMC Musculoskelet Disord."},{"issue":"6","key":"bib8-20250430","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00264-008-0659-z","article-title":"Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study","volume":"33","author":"Memtsoudis","year":"2009","journal-title":"Int Orthop."},{"issue":"12","key":"bib9-20250430","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2106\/JBJS.F.00235","article-title":"Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment","volume":"89","author":"Dorr","year":"2007","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"bib10-20250430","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty."},{"issue":"7","key":"bib11-20250430","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"bib12-20250430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J Arthroplasty."},{"issue":"7","key":"bib13-20250430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1302\/0301-620X.102B7.BJJ-2019-1559.R1","article-title":"Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty","volume":"102-B","author":"Gonzalez Della Valle","year":"2020","journal-title":"Bone Joint J."},{"issue":"3","key":"bib14-20250430","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med."},{"issue":"8","key":"bib15-20250430","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med."},{"issue":"5","key":"bib16-20250430","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.arth.2020.01.013","article-title":"Stratifying venous thromboembolism risk in arthroplasty: do high-risk patients exist?","volume":"35","author":"Landy","year":"2020","journal-title":"J Arthroplasty."},{"issue":"11","key":"bib17-20250430","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1302\/0301-620X.96B11.33492","article-title":"Lower limb joint replacement in patients with a history of venous thromboembolism","volume":"96-B","author":"Allen","year":"2014","journal-title":"Bone Joint J."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.21.00601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:38:03Z","timestamp":1787751483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.21.00601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":17,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.21.00601","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}